Skip to content
Government Federal, Medical Health Aged Care

Health Services Union welcomes major investment in women’s health

Health Services Union < 1 mins read

Monday February 10

Big boost for women’s health is positive, but reproductive health leave is needed

The federal government’s $573 million dollar package to improve access to reproductive health services for women is being warmly received by the Health Services Union.

But the union has cautioned there is still work to be done, including the establishment of universal reproductive health leave.

“This package is definitely a great step, and well overdue. This money will go a long way in helping create a more equitable health system for women,” Health Services Union’s national senior assistant secretary Kate Marshall said.

As part of the package, new oral contraceptive pills will be listed on the PBS for the first time in more than three decades. There will also be more Medicare support for women going through menopause, and subsidies for new hormonal therapies, and increased services for endometriosis and pelvic pain clinics. 

The HSU supports all these measures, but is urging decision makers to seriously consider reproductive health leave as an important missing piece.

“Women experiencing period pain, IVF journeys, miscarriage, terminations, treatments or anything relating to their reproductive health should be able to access specific paid leave and flexibility,” Kate Marshall said.

The HSU, Queensland Council of Unions and Aware Super commissioned research by Bankwest Curtin Economics which found committing to funding 12 days of paid reproductive health leave a year would cost around $900 million, and could save billions in lost productivity.

“Making reproductive health leave a universal entitlement is not only dignifying for Australian women, but it makes economic sense. A huge number of our workers are women, and our leave entitlements should acknowledge our reproductive needs.”

Contact: Kathleen Ferguson  - 0421 522 080

 

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.